Loomis, Sayles & Company
GRDN

Loomis, Sayles & Company’s Guardian Pharmacy Services GRDN Stock Holding History

Loomis, Sayles & Company’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.1M Buy
931,689
+296,068
+47% +$9.67M 0.05% 143
2025
Q4 		$19.1M Buy
+635,621
New +$18M 0.02% 243

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Loomis, Sayles & Company's GRDN Position: Q1 2026 in Review

Loomis, Sayles & Company increased its Guardian Pharmacy Services (GRDN) stake by 47% in Q1 2026, buying an estimated $9.67M and bringing the position to 931,689 shares worth $35.1M. The position accounts for 0.05% of the portfolio, ranked #143.

Loomis, Sayles & Company first reported a position in GRDN in Q4 2025 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Loomis, Sayles & Company held 931,689 shares of Guardian Pharmacy Services worth $35.1M as of Q1 2026.
  • Loomis, Sayles & Company bought 296,068 Guardian Pharmacy Services shares in Q1 2026, an estimated $9.67M.
  • Guardian Pharmacy Services made up 0.05% of Loomis, Sayles & Company's portfolio in Q1 2026, its #143 holding.
  • Loomis, Sayles & Company first reported a position in Guardian Pharmacy Services in Q4 2025 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.